Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study-Reference-Cited by-同舟云学术

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study

Published:2023-03 Issue: Volume:128 Page:166-175
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Kohmer Niko,Stein Shivana,Schenk Barbara,Grikscheit Katharina^ORCID,Metzler Melinda,Rabenau Holger F.,Widera Marek^ORCID,Herrmann Eva^ORCID,Wicker Sabine^ORCID,Ciesek Sandra

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference47 articles.

1. European Medicines Agency. Signal assessment report on embolic and thrombotic events (SMQ) with COVID-19 Vaccine (ChAdOx1-S [recombinant]) – Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (Other viral vaccines), https://www.ema.europa.eu/en/documents/prac-recommendation/signal-assessment-report-embolic-thrombotic-events-smq-covid-19-vaccine-chadox1-s-recombinant_en.pdf; 2021 [accessed 19 August 2022].

2. Robert Koch Institut. Beschluss der STIKO zur 4. Aktualisierung der COVID-19 Impfempfehlung, https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2021/Ausgaben/16_21.pdf?__blob=publicationFile; 2021 [accessed 19 August 2022].

3. Robert Koch Institut. COVID-19-Zielimpfquote: STIKO: 8. Aktualisierung der COVID-19-Impfempfehlung VRE-Jahresbericht, https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2021/Ausgaben/27_21.pdf?__blob=publicationFile; 2021 [accessed 19 August 2022].

4. Immunogenicity and safety of homologous and heterologous prime-boost immunization with COVID-19 vaccine: systematic review and meta-analysis;Cheng;Vaccines,2022

5. To mix or not to mix? A rapid systematic review of heterologous prime-boost Covid-19 vaccination;Chiu;Expert Rev Vaccines,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants;iScience;2024-09

2. Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron;Frontiers in Immunology;2023-11-10

3. Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination;Frontiers in Immunology;2023-10-26

4. Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron;2023-10-06

5. Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study;RMD Open;2023-08